MapLight Therapeutics, Inc.

NASDAQ:MPLT

Biotechnology

Healthcare
$6.65 +3.11%

+$0.39 today

Market cap
$283.41M
Beta
2.65
P/E (TTM)
-2.8
EPS (TTM)
-$4.41
52W Low $9.10High $40.43

Volume 0.42M

Average 0.73M

MPLT Total Non-current Assets

All assets not expected to be converted to cash within one year.

MapLight Therapeutics, Inc.NASDAQ: MPLT

Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026

Total non-current assets rises 588.3% from a year ago

Total non-current assets stood at $91.56M at the end of Q1 FY2026, up 588.3% from a year earlier and down 40.9% from the prior quarter. Over 3 fiscal years it compounded at +176.1% a year.

Context

  • Total non-current assets amounted to 21.9% of total assets at the end of Q1 FY2026, up 9.9 pp from a year earlier.
  • Total non-current assets increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether total non-current assets keeps rising in the next quarterly balance sheet after a +588.3% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$91.56M-40.9% QoQ
Last fiscal yearDec 2025
$154.84M+593.9% YoY
Year agoMar 2025
$13.3M+588.3% since
Total Non-current Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+588.3%——
1 year+593.9%——
3-year CAGR+176.1%——
5-year CAGR——
10-year CAGR——

Total Non-current Assets history

USD · from the balance sheet

Latest · FY2025
154.84M USD
Year-over-year change
+593.9%
3-year CAGR
+176.1%

Total Non-current Assets vs competitors

How MPLT compares with its peers on the latest reported figures

  • MPLT's Mar 2026 total non-current assets of $91.56M is the 2nd highest of the 11 companies compared; the peer median is $10.02M.
  • Its year-over-year change of +588.3% is the 2nd highest of 10, against a peer median of -1.3%.
  • Total non-current assets amounts to 21.9% of total assets for MPLT, versus a peer median of 2.3%.
MPLT Competitors Peer median
Total Non-current Assets for MPLT and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
NERVMinerva Neurosciences, Inc.Jun 2026$15.36B +103156.5%-0.1%16.1%
MPLTMapLight Therapeutics, Inc.Mar 2026$91.56M +588.3%+176.1%21.9%
OVIDOvid Therapeutics Inc.Mar 2026$65.48M +83.3%+36.3%29.0%
ZVRAZevra Therapeutics, Inc.Mar 2026$48.61M -46.7%+40.0%17.4%
DFTXDefinium Therapeutics, Inc.Sep 2026$22.52M +6.9%-4.6%2.1%
RAPPRapport Therapeutics, Inc. Common StockMar 2026$12.9M +16.4%+245.9%2.6%
ANROAlto Neuroscience, Inc.Mar 2026$7.13M -15.0%+62.2%2.6%
LBRXLB Pharmaceuticals Inc Common StockMar 2026$4.41M -1.3%+1044.9%1.1%
GHRSGH Research PLCMar 2026$3.04M -88.2%-70.3%1.1%
NMRANeumora Therapeutics, Inc. Common StockMar 2026$443K -76.5%-76.3%0.3%
AVXLAnavex Life Sciences Corp.Dec 2025$0 ——0.0%
Peer median (excluding MPLT) $10.02M-1.3%+36.3%2.3%

Competitors are the stored peer set for MPLT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents27.67M79.77M38.25M46.73M
Short-term Investments0070.54M258.37M
Net Receivables0000
Inventory0000
Other Current Assets4.37M0019.57M
Total Current Assets32.03M83.6M114.6M324.67M
Property, Plant & Equipment (Net)7.12M6.59M7.56M6.58M
Goodwill0000
Intangible Assets0000
Long-term Investments234K1.22M11.59M148.2M
Tax Assets0000
Other Non-current Assets234K234K3.17M59K
Total Non-current Assets7.36M7.81M22.31M154.84M
Total Assets39.39M91.41M136.92M479.51M
Account Payables3.6M3.25M1.91M0
Short-term Debt348K495K778K891K
Tax Payables0000
Deferred Revenue5.86M4.2M3.24M0
Other Current Liabilities1.34M4M5.98M9.18M
Total Current Liabilities12.6M14.7M15.92M16.23M
Long-term Debt0000
Deferred Tax Liabilities0000
Deferred Revenue (Non-current)0000
Other Non-current Liabilities0000
Total Non-current Liabilities5.92M5.43M5.8M4.91M
Total Liabilities18.52M20.13M21.72M21.14M
Common Stock0005K
Retained Earnings(66.08M)(121.79M)(199.37M)(360.52M)
Accumulated OCI00163K(228K)
Other Stockholders Equity(1)000
Minority Interest0000
Total Equity20.87M71.28M115.2M458.37M
Total Debt6.27M5.92M6.58M5.8M
Net Debt(21.39M)(73.85M)(31.67M)(40.93M)

MapLight Therapeutics, Inc.

NASDAQ:MPLT

Intrinsic Alpha fair value

Locked

Current Price

$6.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.